Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating TNF-.alpha.-mediated Crohn's disease using chimeric anti-TNF antibodies

Methods of treating TNF-.alpha.-mediated Crohn's disease using chimeric anti-TNF antibodies

US Patent 5656272 · Granted Aug 12, 1997

Estimated economic value: $35,940,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-IL-6 antibody2024
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody2021
Method for treating lupus by administering an anti-IL-12 antibody2021
Method for treating lupus by administering an anti-IL-12 antibody2019
Method for treating lupus by administering an anti-IL-12 antibody2019
Method of treating lupus by administering an anti-IL-12 antibody2018
Anti-TNF antibodies, compositions, methods and uses2017
Anti-IL-12 antibodies and compositions2017
Pen-injector device containing anti-IL-6 antibodies2017
Nucleic acids encoding anti-IL-12 antibody2017
Immunoglobulin cleavage fragments and disease indicators and compositions for de2016
Method of treating Crohn's disease by administering an anti-IL-12 antibody2016